SCA
KNSA icon

Spearhead Capital Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Spearhead Capital Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.6M Sell
202,580
-32,444
-14% -$370K 2.82% 5
2022
Q2 		$2.28M Hold
235,024
– – 0.34% 54
2022
Q1 		$2.34M Hold
235,024
– – 0.29% 56
2021
Q4 		$2.77M Hold
235,024
– – 0.33% 56
2021
Q3 		$2.68M Hold
235,024
– – 0.36% 52
2021
Q2 		$3.27M Sell
235,024
-141,821
-38% -$2.15M 0.45% 56
2021
Q1 		$6.97M Buy
376,845
+106,728
+40% +$2.18M 1.03% 55
2020
Q4 		$4.77M Hold
270,117
– – 0.76% 56
2020
Q3 		$4.14M Sell
270,117
-678
-0.3% -$12.7K 0.79% 56
2020
Q2 		$6.9M Hold
270,795
– – 1.47% 17
2020
Q1 		$4.19M Buy
+270,795
New +$4.24M 1.21% 44

Other funds holding KNSA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return